Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Non-Current Assets Non-Current Debt Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

InspireMD (NSPR) Preferred Stock Liabilities (2017 - 2018)

InspireMD filings provide 2 years of Preferred Stock Liabilities readings, the most recent being $2.3 million for Q2 2018.

On a quarterly basis, Preferred Stock Liabilities changed N/A to $2.3 million in Q2 2018 year-over-year; TTM through Jun 2018 was $2.3 million, a N/A change, with the full-year FY2017 number at $274000.0, changed N/A from a year prior.
Preferred Stock Liabilities hit $2.3 million in Q2 2018 for InspireMD, up from $1.8 million in the prior quarter.
In the past five years, Preferred Stock Liabilities ranged from a high of $2.3 million in Q2 2018 to a low of $274000.0 in Q4 2017.